Impact of insulin pump on quality of life of diabetic patients

Indian Journal of Endocrinology and Metabolism

Volumn 20, Issue 4, 2016, Pages 506-511

  Ghazanfar, Haider ^a   Rizvi, Syed ^b   Khurram, Aliya ^a   Orooj, Fizza ^a   Qaiser, Iman ^a  

^a R Endocrinology Clinic   (United States)

^b ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Insulin; patients with type 2 diabetes; quality of life

Indexed keywords

EID: 84975065631     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.183472     Document Type: Article

References (41)

1. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. Adv Exp Med Biol 2012;771:1-11
2. Yisahak SF, Beagley J, Hambleton IR, Narayan KM; IDF Diabetes Atlas. Diabetes in North America and the Caribbean: An update. Diabetes Res Clin Pract 2014;103:223-30
3. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 27 million participants. Lancet 2011;378:31-40
4. WHO Diabetes Fact Sheet No. 312. Reviewed October, 2013. Available from: http://www.who.int/mediacentre/factsheets/fs312/ en/. [Last accessed on 2015 Dec 28]
5. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-12
6. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005;28:2948-61
7. American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015;38 Suppl: S8-16
8. Kazemi-Galougahi MH, Ghaziani HN, Ardebili HE, Mahmoudi M. Quality of life in type 2 diabetic patients and related effective factors. Indian J Med Sci 2012;66:230-7
9. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979;300:573-8
10. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: An approach to achieving normoglycaemia. Br Med J 1978;1:204-7
11. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Care 2016.pii: dc151990. [Epub ahead of print]
12. Writing Group for the DCCT/EDIC Research Group, Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 2015;313:45-53
13. Berthe E, Lireux B, Coffin C, Goulet-Salmon B, Houlbert D, Boutreux S, et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: A comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res 2007;39:224-9
14. Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: Systematic review and economic evaluation. Health Technol Assess 2010;14:iii-iv, xi-xvi, 1-181
15. Monami M, Lamanna C, Marchionni N, Mannucci E. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: A meta-analysis. Acta Diabetol 2010;47 Suppl 1:77-81
16. Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. Multiple daily injections in children with type 1 diabetes: A systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009;10:52-8
17. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: A meta-analysis. Diabetes Care 2003;26:1079-87
18. Ali A, Iqbal F, Taj A, Iqbal Z, Amin MJ, Iqbal QZ. Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes. Pak J Med Sci 2013;29:899-902
19. Bash LD, Selvin E, Steffes M, Coresh J, Astor BC. Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis risk in communities (ARIC) Study. Arch Intern Med 2008;168:2440-7
20. Lepore G, Bruttomesso D, Bonomo M, Dodesini AR, Costa S, Meneghini E, et al. Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients. Diabet Med 2009;26:602-8
21. Awoniyi O, Rehman R, Dagogo-Jack S. Hypoglycemia in patients with type 1 diabetes: Epidemiology, pathogenesis, and prevention. Curr Diab Rep 2013;13:669-78
22. Didangelos T, Iliadis F. Insulin pump therapy in adults. Diabetes Res Clin Pract 2011;93 Suppl 1:S109-13
23. Pickup JC, Renard E. Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 2008;31 Suppl 2:S140-5
24. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: Hypoglycemia with intensive insulin therapy: A systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009;94:729-40
25. Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care 2003;26:2598-603
26. Pouwels MJ, Tack CJ, Hermus AR, Lutterman JA. Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients. Diabet Med 2003;20:76-9
27. Peters JE, Mount E, Huggins CE, Rodda C, Silvers MA. Insulin pump therapy in children and adolescents: Changes in dietary habits, composition and quality of life. J Paediatr Child Health 2013;49:E300-5
28. Aronson R, Reznik Y, Conget I, Castañeda JA, de Portu S, Runzis S, et al. Sustained efficacy of insulin pump therapy, compared with multiple daily injections, in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obes Metab 2016;doi:10.1111/dom.12642
29. EQuality Study Group - Evaluation of QUALITY of Life and Costs in Diabetes Type, Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, et al. Quality of life and treatment satisfaction in adults with Type 1 diabetes: A comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med 2008;25:213-20
30. Hirose M, Beverly EA, Weinger K. Quality of life and technology: impact on children and families with diabetes. Curr Diab Rep 2012;12:711-20
31. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: Results of the 5-nations trial. Diabet Med 2006;23:141-7
32. Reznik Y, Cohen O. Insulin pump for type 2 diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes. Diabetes Care 2013;36 Suppl 2:S219-25
33. Kaur G, Tee GH, Ariaratnam S, Krishnapillai AS, China K. Depression, anxiety and stress symptoms among diabetics in Malaysia: A cross sectional study in an urban primary care setting. BMC Fam Pract 2013;14:69
34. Azimova K, Rude J, Mallawaarachchi I, Dwivedi A, Sarosiek J, Mukherjee D. Glucose levels and depression in Hispanic patients admitted to the cardiovascular intensive care unit: A cross-sectional study. Angiology 2015;66:57-64
35. Bajaj S, Agarwal SK, Varma A, Singh VK. Association of depression and its relation with complications in newly diagnosed type 2 diabetes. Indian J Endocrinol Metab 2012;16:759-63
36. Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health 2007;7:186
37. Clouet F, Excler-Cavailher G, Christophe B, Masson F, Fasquel D. Type 2 diabetes and short form 36-items health survey. Diabetes Metab 2001;27:711-7
38. Health Quality Ontario. Continuous Subcutaneous Insulin Infusion (CSII) pumps for type 1 and type 2 adult diabetic populations: An evidence-based analysis. Ont Health Technol Assess Ser 2009;9:1-58
39. Fendler W, Baranowska AI, Mianowska B, Szadkowska A, Mlynarski W. Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes. Acta Diabetol 2012;49:363-70
40. Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005;28:1568-73
41. Low KG, Massa L, Lehman D, Olshan JS. Insulin pump use in young adolescents with type 1 diabetes: A descriptive study. Pediatr Diabetes 2005;6:22-31.